Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data

R Romero, A Conde-Agudelo, W El-Refaie, L Rode, M L Brizot, E Cetingoz, V Serra, E Da Fonseca, M S Abdelhafez, A Tabor, A Perales, S S Hassan, K H Nicolaides, R Romero, A Conde-Agudelo, W El-Refaie, L Rode, M L Brizot, E Cetingoz, V Serra, E Da Fonseca, M S Abdelhafez, A Tabor, A Perales, S S Hassan, K H Nicolaides

Abstract

Objective: To assess the efficacy of vaginal progesterone for the prevention of preterm birth and neonatal morbidity and mortality in asymptomatic women with a twin gestation and a sonographic short cervix (cervical length ≤ 25 mm) in the mid-trimester.

Methods: This was an updated systematic review and meta-analysis of individual patient data (IPD) from randomized controlled trials comparing vaginal progesterone with placebo/no treatment in women with a twin gestation and a mid-trimester sonographic cervical length ≤ 25 mm. MEDLINE, EMBASE, POPLINE, CINAHL and LILACS (all from inception to 31 December 2016), the Cochrane Central Register of Controlled Trials, Research Registers of ongoing trials, Google Scholar, conference proceedings and reference lists of identified studies were searched. The primary outcome measure was preterm birth < 33 weeks' gestation. Two reviewers independently selected studies, assessed the risk of bias and extracted the data. Pooled relative risks (RRs) with 95% confidence intervals (CI) were calculated.

Results: IPD were available for 303 women (159 assigned to vaginal progesterone and 144 assigned to placebo/no treatment) and their 606 fetuses/infants from six randomized controlled trials. One study, which included women with a cervical length between 20 and 25 mm, provided 74% of the total sample size of the IPD meta-analysis. Vaginal progesterone, compared with placebo/no treatment, was associated with a statistically significant reduction in the risk of preterm birth < 33 weeks' gestation (31.4% vs 43.1%; RR, 0.69 (95% CI, 0.51-0.93); moderate-quality evidence). Moreover, vaginal progesterone administration was associated with a significant decrease in the risk of preterm birth < 35, < 34, < 32 and < 30 weeks' gestation (RRs ranging from 0.47 to 0.83), neonatal death (RR, 0.53 (95% CI, 0.35-0.81)), respiratory distress syndrome (RR, 0.70 (95% CI, 0.56-0.89)), composite neonatal morbidity and mortality (RR, 0.61 (95% CI, 0.34-0.98)), use of mechanical ventilation (RR, 0.54 (95% CI, 0.36-0.81)) and birth weight < 1500 g (RR, 0.53 (95% CI, 0.35-0.80)) (all moderate-quality evidence). There were no significant differences in neurodevelopmental outcomes at 4-5 years of age between the vaginal progesterone and placebo groups.

Conclusion: Administration of vaginal progesterone to asymptomatic women with a twin gestation and a sonographic short cervix in the mid-trimester reduces the risk of preterm birth occurring at < 30 to < 35 gestational weeks, neonatal mortality and some measures of neonatal morbidity, without any demonstrable deleterious effects on childhood neurodevelopment. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Keywords: cervical length; prematurity; preterm delivery; progestins; progestogens; transvaginal ultrasound.

Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Figures

Figure 1
Figure 1
Study selection process. CL, cervical length.
Figure 2
Figure 2
Risk of bias of studies included in the systematic review. , low risk of bias; , high risk of bias; , unclear risk of bias.
Figure 3
Figure 3
Forest plot of the effect of vaginal progesterone on the risk of preterm birth

References

    1. Ananth CV, Chauhan SP. Epidemiology of twinning in developed countries. Semin Perinatol 2012; 36: 156–161.
    1. Martin JA, Hamilton BE, Osterman MJ. Three decades of twin births in the United States, 1980–2009. NCHS Data Brief 2012; 80: 1–8.
    1. Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V. Twins: prevalence, problems, and preterm births. Am J Obstet Gynecol 2010; 203: 305–315.
    1. Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ. Births: Final Data for 2014. Natl Vital Stat Rep 2015; 64: 1–64.
    1. Conde‐Agudelo A, Belizán JM, Lindmark G. Maternal morbidity and mortality associated with multiple gestations. Obstet Gynecol 2000; 95: 899–904.
    1. Blickstein I. Maternal mortality in twin gestations. J Reprod Med 1997; 42: 680–684.
    1. Kinzler WL, Ananth CV, Vintzileos AM. Medical and economic effects of twin gestations. J Soc Gynecol Investig 2000; 7: 321–327.
    1. Walker MC, Murphy KE, Pan S, Yang Q, Wen SW. Adverse maternal outcomes in multifetal pregnancies. BJOG 2004; 111: 1294–1296.
    1. Vogel JP, Torloni MR, Seuc A, Betrán AP, Widmer M, Souza JP, Merialdi M. Maternal and perinatal outcomes of twin pregnancy in 23 low‐ and middle‐income countries. PLoS One 2013; 8: e70549.
    1. Burgess JL, Unal ER, Nietert PJ, Newman RB. Risk of late‐preterm stillbirth and neonatal morbidity for monochorionic and dichorionic twins. Am J Obstet Gynecol 2014; 210: 578.e1–9.
    1. Blickstein I. Do multiple gestations raise the risk of cerebral palsy? Clin Perinatol 2004; 31: 395–408.
    1. Pharoah PO. Risk of cerebral palsy in multiple pregnancies. Clin Perinatol 2006; 33: 301–313.
    1. Lorenz JM. Neurodevelopmental outcomes of twins. Semin Perinatol 2012; 36: 201–212.
    1. Luke B, Brown MB, Alexandre PK, Kinoshi T, O'Sullivan MJ, Martin D, Misiunas RB, Nugent C, van de Ven C, Newman RB, Mauldin JG, Witter FR. The cost of twin pregnancy: maternal and neonatal factors. Am J Obstet Gynecol 2005; 192: 909–915.
    1. Henderson J, Hockley C, Petrou S, Goldacre M, Davidson L. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life. Arch Dis Child Fetal Neonatal Ed 2004; 89: F542–F545.
    1. Crowther CA, Han S. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev 2010; 7: CD000110.
    1. Yamasmit W, Chaithongwongwatthana S, Tolosa JE, Limpongsanurak S, Pereira L, Lumbiganon P. Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy. Cochrane Database Syst Rev 2015; 12: CD004733.
    1. Goodnight W, Newman R; Society of Maternal‐Fetal Medicine . Optimal nutrition for improved twin pregnancy outcome. Obstet Gynecol 2009; 114: 1121–1134.
    1. Schuit E, Stock S, Rode L, Rouse DJ, Lim AC, Norman JE, Nassar AH, Serra V, Combs CA, Vayssiere C, Aboulghar MM, Wood S, Çetingöz E, Briery CM, Fonseca EB, Worda K, Tabor A, Thom EA, Caritis SN, Awwad J, Usta IM, Perales A, Meseguer J, Maurel K, Garite T, Aboulghar MA, Amin YM, Ross S, Cam C, Karateke A, Morrison JC, Magann EF, Nicolaides KH, Zuithoff NP, Groenwold RH, Moons KG, Kwee A, Mol BW; Global Obstetrics Network (GONet) collaboration . Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta‐analysis. BJOG 2015; 122: 27–37.
    1. Rafael TJ, Berghella V, Alfirevic Z. Cervical stitch (cerclage) for preventing preterm birth in multiple pregnancy. Cochrane Database Syst Rev 2014; 9: CD009166.
    1. Liem S, Schuit E, Hegeman M, Bais J, de Boer K, Bloemenkamp K, Brons J, Duvekot H, Bijvank BN, Franssen M, Gaugler I, de Graaf I, Oudijk M, Papatsonis D, Pernet P, Porath M, Scheepers L, Sikkema M, Sporken J, Visser H, van Wijngaarden W, Woiski M, van Pampus M, Mol BW, Bekedam D. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open‐label randomised controlled trial. Lancet 2013; 382: 1341–1349.
    1. Nicolaides KH, Syngelaki A, Poon LC, de Paco Matallana C, Plasencia W, Molina FS, Picciarelli G, Tul N, Celik E, Lau TK, Conturso R. Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial. Am J Obstet Gynecol 2016; 214: 3.e1–9.
    1. Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334: 567–572.
    1. Hassan SS, Romero R, Berry SM, Dang K, Blackwell SC, Treadwell MC, Wolfe HM. Patients with an ultrasonographic cervical length < or =15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 1458–1467.
    1. Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound Obstet Gynecol 2003; 22: 305–322.
    1. Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol 2008; 31: 579–587.
    1. Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, Roberts TE, Barton PM, Jowett SM, Hyde CJ, Khan KS. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009; 13: 1–627.
    1. Domin CM, Smith EJ, Terplan M. Transvaginal ultrasonographic measurement of cervical length as a predictor of preterm birth: a systematic review with meta‐analysis. Ultrasound Q 2010; 26: 241–248.
    1. Barros‐Silva J, Pedrosa AC, Matias A. Sonographic measurement of cervical length as a predictor of preterm delivery: a systematic review. J Perinat Med 2014; 42: 281–293.
    1. Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, Caritis SN, McNellis D. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal‐Fetal Medicine Units Network. Am J Obstet Gynecol 1996; 175: 1047–1053.
    1. Gibson JL, Macara LM, Owen P, Young D, Macauley J, Mackenzie F. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol 2004; 23: 561–566.
    1. Sperling L, Kiil C, Larsen LU, Qvist I, Bach D, Wøjdemann K, Bladh A, Nikkilä A, Jørgensen C, Skajaa K, Bang J, Tabor A. How to identify twins at low risk of spontaneous preterm delivery. Ultrasound Obstet Gynecol 2005; 26: 138–144.
    1. Arabin B, Roos C, Kollen B, van Eyck J. Comparison of transvaginal sonography in recumbent and standing maternal positions to predict spontaneous preterm birth in singleton and twin pregnancies. Ultrasound Obstet Gynecol 2006; 27: 377–386.
    1. To MS, Fonseca EB, Molina FS, Cacho AM, Nicolaides KH. Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins. Am J Obstet Gynecol 2006; 194: 1360–1365.
    1. Conde‐Agudelo A, Romero R, Hassan SS, Yeo L. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol 2010; 203: 128.e1–12.
    1. Lim AC, Hegeman MA, Huis In ‘T Veld MA, Opmeer BC, Bruinse HW, Mol BW. Cervical length measurement for the prediction of preterm birth in multiple pregnancies: a systematic review and bivariate meta‐analysis. Ultrasound Obstet Gynecol 2011; 38: 10–17.
    1. Kindinger L, Ashrafian H, Poon L, Fox NS, Nicolaides K, Darzi K, Teoh TG, Bennett P. Prediction of preterm delivery with cervical length in twin pregnancy: A meta‐analysis and systematic review. Reprod Sci 2014; 21: 256A.
    1. Conde‐Agudelo A, Romero R. Prediction of preterm birth in twin gestations using biophysical and biochemical tests. Am J Obstet Gynecol 2014; 211: 583–595.
    1. Conde‐Agudelo A, Romero R. Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 2015; 213: 789–801.
    1. Pagani G, Stagnati V, Fichera A, Prefumo F. Cervical length at mid‐gestation in screening for preterm birth in twin pregnancy. Ultrasound Obstet Gynecol 2016; 48: 56–60.
    1. Kindinger LM, Poon LC, Cacciatore S, MacIntyre DA, Fox NS, Schuit E, Mol BW, Liem S, Lim AC, Serra V, Perales A, Hermans F, Darzi A, Bennett P, Nicolaides KH, Teoh TG. The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta‐analysis. BJOG 2016; 123: 877–884.
    1. Melamed N, Pittini A, Hiersch L, Yogev Y, Korzeniewski SS, Romero R, Barrett J. Serial cervical length determination in twin pregnancies reveals 4 distinct patterns with prognostic significance for preterm birth. Am J Obstet Gynecol 2016; 215: 476.e1–476.e11.
    1. Melamed N, Pittini A, Hiersch L, Yogev Y, Korzeniewski SJ, Romero R, Barrett J. Do serial measurements of cervical length improve the prediction of preterm birth in asymptomatic women with twin gestations? Am J Obstet Gynecol 2016; 215: 616.e1–616.e14.
    1. Romero R, Nicolaides KH, Conde‐Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol 2016: 48: 308–317.
    1. Conde‐Agudelo A, Romero R. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Am J Obstet Gynecol 2016; 214: 235–242.
    1. Romero R, Yeo L, Miranda J, Hassan SS, Conde‐Agudelo A, Chaiworapongsa T. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med 2013; 41: 27–44.
    1. Romero R, Nicolaides K, Conde‐Agudelo A, Tabor A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Klein K, Rode L, Soma‐Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206: 124.e1–19.
    1. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–34.
    1. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies In Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011), Higgins JPT, Green S. (eds). The Cochrane Collaboration, 2011. Available from
    1. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta‐analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005; 2: 209–217.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003; 327: 557–560.
    1. Gates S, Brocklehurst P. How should randomised trials including multiple pregnancies be analysed? BJOG 2004; 111: 213–219.
    1. Yelland LN, Salter AB, Ryan P, Makrides M. Analysis of binary outcomes from randomised trials including multiple births: when should clustering be taken into account? Paediatr Perinat Epidemiol 2011; 25: 283–297.
    1. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics In Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011), Higgins JPT, Green S. (eds). The Cochrane Collaboration, 2011. Available at .
    1. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998; 317: 1309–1312.
    1. Rothwell PM. Treating individuals 2. Subgroup analysis in randomized controlled trials: importance, indications, and interpretation. Lancet 2005; 365: 176–186.
    1. Klebanoff MA. Subgroup analysis in obstetrics clinical trials. Am J Obstet Gynecol 2007; 197: 119–122.
    1. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analyzing data and undertaking meta‐analyses In Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011), Higgins JPT, Green S. (eds). The Cochrane Collaboration, 2011. Available at .
    1. Schünemann H, Brożek J, Guyatt G, Oxman A (eds). GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. Updated October 2013. The GRADE Working Group, 2013. Available at .
    1. GRADEpro GDT: GRADEpro Guideline Development Tool [Software] . McMaster University, 2015. (developed by Evidence Prime, Inc.). Available from
    1. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, Calder A, Mires G, Danielian P, Sturgiss S, MacLennan G, Tydeman G, Thornton S, Martin B, Thornton JG, Neilson JP, Norrie J. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double‐blind, placebo‐controlled study and meta‐analysis. Lancet 2009; 373: 2034–2040.
    1. Wood S, Ross S, Tang S, Miller L, Sauve R, Brant R. Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. J Perinat Med 2012; 40: 593–599.
    1. Aboulghar MM, Aboulghar MA, Amin YM, Al‐Inany HG, Mansour RT, Serour GI. The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies. Reprod Biomed Online 2012; 25: 133–138.
    1. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Group Fetal Medicine Foundation Second Trimester Screening. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462–469.
    1. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high‐risk pregnancies: a randomized placebo‐controlled trial. Arch Gynecol Obstet 2011; 283: 423–429.
    1. Rode L, Klein K, Nicolaides KH, Krampl‐Bettelheim E, Tabor A; PREDICT Group . Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo‐controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011; 38: 272–280.
    1. Serra V, Perales A, Meseguer J, Parrilla JJ, Lara C, Bellver J, Grifol R, Alcover I, Sala M, Martínez‐Escoriza JC, Pellicer A. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double‐blind multicentre trial. BJOG 2013; 120: 50–57.
    1. Brizot ML, Hernandez W, Liao AW, Bittar RE, Francisco RP, Krebs VL, Zugaib M. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo‐controlled double‐blind study. Am J Obstet Gynecol 2015; 213: 82.e1–9.
    1. El‐Refaie W, Abdelhafez MS, Badawy A. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. Arch Gynecol Obstet 2016; 293: 61–67.
    1. McNamara HC, Wood R, Chalmers J, Marlow N, Norrie J, MacLennan G, McPherson G, Boachie C, Norman JE. STOPPIT Baby Follow‐up Study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome. PLoS One 2015; 10: e0122341.
    1. Vedel C, Larsen H, Holmskov A, Andreasen KR, Uldbjerg N, Ramb J, Bødker B, Skibsted L, Sperling L, Krebs L, Zingenberg H, Laursen L, Christensen JT, Tabor A, Rode L. Long‐term effects of prenatal progesterone exposure: neurophysiological development and hospital admissions in twins up to 8 years of age. Ultrasound Obstet Gynecol 2016; 48: 382–389.
    1. Schumacher M, Denier C, Oudinet JP, Adams D, Guennoun R. Progesterone neuroprotection: The background of clinical trial failure. J Steroid Biochem Mol Biol 2016; 160: 53–66.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa